UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 27

Sortiert nach

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma

Scientific reports, 2021-02, Vol.11 (1), p.2967-2967, Article 2967

2021

Volltextzugriff (PDF)

A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma

Scientific reports, 2017-12, Vol.7 (1), p.17751-11, Article 17751

2017

Volltextzugriff (PDF)

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma

Scientific reports, 2021-10, Vol.11 (1), p.19916-19916, Article 19916

2021

Volltextzugriff (PDF)

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy

Apoptosis (London), 2013-10, Vol.18 (10), p.1224-1234

2013

Volltextzugriff (PDF)

Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)

Pathology, research and practice, 2024-03, Vol.255, p.155163-155163, Article 155163

2024

Volltextzugriff (PDF)

Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation

Oncology reports, 2019-01, Vol.41 (1), p.143-153

2019

Volltextzugriff (PDF)

Development of Iodinated Indocyanine Green Analogs as a Strategy for Targeted Therapy of Liver Cancer

ACS medicinal chemistry letters, 2023-09, Vol.14 (9), p.1208-1215

2023

Volltextzugriff (PDF)

An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer

Hepatology communications, 2024-06, Vol.8 (6)

2024

Volltextzugriff (PDF)

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy

Apoptosis (London), 2013-10, Vol.18 (10), p.1224-1234

2013

Volltextzugriff (PDF)

EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma

Oncotarget, 2017-11, Vol.8 (55), p.94780-94792

2017

Volltextzugriff (PDF)

DUSP26 is a transcriptional target of MYCN in neuroblastoma

Journal of the American College of Surgeons, 2013-09, Vol.217 (3), p.S81-S82

2013

Volltextzugriff (PDF)

Abstract 386: Targeting MDM4 to reactivate p53 signaling in neuroblastoma

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.386-386

2019

Volltextzugriff (PDF)

Abstract B36: Targeting MDM4 in neuroblastoma to reactivate p53 signaling

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (19_Supplement), p.B36-B36

2018

Volltextzugriff (PDF)

Abstract B35: Reactivation of p53 signaling in hepatoblastoma with a stapled peptide dual inhibitor of MDM2 and MDM4

Cancer research (Chicago, Ill.), 2018-10, Vol.78 (19_Supplement), p.B35-B35

2018

Volltextzugriff (PDF)

Abstract B76: Characterizing vascular invasion in hepatoblastoma

Cancer research (Chicago, Ill.), 2020-07, Vol.80 (14_Supplement), p.B76-B76

2020

Volltextzugriff (PDF)

Abstract 4127: Targeting MDM4 in hepatocellular carcinoma to reactivate p53 signaling

Cancer research (Chicago, Ill.), 2017-07, Vol.77 (13_Supplement), p.4127-4127

2017

Volltextzugriff (PDF)

Abstract 2997: Novel orthotopic patient-derived xenograft mouse models of hepatoblastoma that replicate tumor heterogeneity, chemoresistance, and refractory disease

Cancer research (Chicago, Ill.), 2021-07, Vol.81 (13_Supplement), p.2997-2997

2021

Volltextzugriff (PDF)

Abstract A008: An indocyanine green-based liquid biopsy test for circulating tumor cells for hepatoblastoma

Cancer research (Chicago, Ill.), 2023-01, Vol.83 (2_Supplement_2), p.A008-A008

2023

Volltextzugriff (PDF)

Abstract PO013: Patient-derived xenograft mouse models of hepatoblastoma for a personalized medicine pipeline

Clinical cancer research, 2022-09, Vol.28 (17_Supplement), p.PO013-PO013

2022

Volltextzugriff (PDF)

Abstract LB-352: DUSP26 inhibition: a new therapeutic pathway in neuroblastoma

Cancer research (Chicago, Ill.), 2013-04, Vol.73 (8_Supplement), p.LB-352-LB-352

2013

Volltextzugriff (PDF)

Twitter at the 2014 and 2015 Annual Meetings of the American Academy of Ophthalmology

Ophthalmology (Rochester, Minn.), 2016-08, Vol.123 (8), p.1835-1837

2016

Volltextzugriff (PDF)

Gender Differences in Patient‐described Pain, Stress, and Anxiety Among Patients Undergoing Treatment for Painful Conditions in the Emergency Department

Academic emergency medicine, 2014-12, Vol.21 (12), p.1478-1484

2014

Volltextzugriff (PDF)

An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle

Clinical ophthalmology (Auckland, N.Z.), 2016-01, Vol.10, p.1411-1417

2016

Volltextzugriff (PDF)

1 – 25 von 27

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(25)

Publikationsform

Artikel
(27)

Sprache

Englisch
(27)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(14)
Life Sciences & Biomedicine
(12)
Humans
(6)
Liver Cancer
(5)
Animal Models
(4)
Animals
(4)
Female
(4)
Gene Expression
(4)
Hepatoblastoma
(4)
Oncology
(4)
Tumors
(4)
Carcinoma, Hepatocellular - Pathology
(3)
Chemotherapy
(3)
Heterografts
(3)
Liver
(3)
Magnetic Resonance Imaging
(3)
Male
(3)
Mice
(3)
Adolescent
(2)
Apoptosis
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma

A Novel Cell Line Based Orthotopic Xenograft Mouse Model That Recapitulates Human Hepatoblastoma

Author Correction: MDM4 inhibition: a novel therapeutic strategy to reactivate p53 in hepatoblastoma

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy

A novel treatment strategy utilizing panobinostat for high-risk and treatment-refractory hepatoblastoma

Histopathologic and immunophenotypic characterization of patient-derived pediatric malignant hepatocellular tumor xenografts (PDXs)

Targeting LRH‑1 in hepatoblastoma cell lines causes decreased proliferation

Development of Iodinated Indocyanine Green Analogs as a Strategy for Targeted Therapy of Liver Cancer

An indocyanine green-based liquid biopsy test for circulating tumor cells for pediatric liver cancer

TAK1 inhibitor 5Z-7-oxozeaenol sensitizes neuroblastoma to chemotherapy

HepT1-derived murine models of high-risk hepatoblastoma display vascular invasion, metastasis, and circulating tumor cells

EWS-FLI1 and RNA helicase A interaction inhibitor YK-4-279 inhibits growth of neuroblastoma

DUSP26 is a transcriptional target of MYCN in neuroblastoma

Abstract 386: Targeting MDM4 to reactivate p53 signaling in neuroblastoma

Abstract B36: Targeting MDM4 in neuroblastoma to reactivate p53 signaling

Abstract B35: Reactivation of p53 signaling in hepatoblastoma with a stapled peptide dual inhibitor of MDM2 and MDM4

Abstract B76: Characterizing vascular invasion in hepatoblastoma

Abstract 4127: Targeting MDM4 in hepatocellular carcinoma to reactivate p53 signaling

Abstract 2997: Novel orthotopic patient-derived xenograft mouse models of hepatoblastoma that replicate tumor heterogeneity, chemoresistance, and refractory disease

Abstract A008: An indocyanine green-based liquid biopsy test for circulating tumor cells for hepatoblastoma

Abstract PO013: Patient-derived xenograft mouse models of hepatoblastoma for a personalized medicine pipeline

Abstract LB-352: DUSP26 inhibition: a new therapeutic pathway in neuroblastoma

Twitter at the 2014 and 2015 Annual Meetings of the American Academy of Ophthalmology

Gender Differences in Patient‐described Pain, Stress, and Anxiety Among Patients Undergoing Treatment for Painful Conditions in the Emergency Department

An upright eyedrop bottle: accuracy, usage of excess drops, and contamination compared to a conventional bottle

Suchergebnisse filtern